UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001955
Receipt number R000002384
Scientific Title Establishment of respiratory biomarker by metabolome
Date of disclosure of the study information 2009/05/11
Last modified on 2009/05/11 16:04:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of respiratory biomarker by metabolome

Acronym

Establishment of respiratory biomarker

Scientific Title

Establishment of respiratory biomarker by metabolome

Scientific Title:Acronym

Establishment of respiratory biomarker

Region

Japan


Condition

Condition

lung cancer, bronchial asthma, sleep apnea

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Detect and establish of new respiratory biomaker by metabolome analysis

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

discovery of new protein as respiratory biomaker

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

surgery

Interventions/Control_2

anti cancer drug

Interventions/Control_3

steroid therapy

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

The patients with lung cancer will be treated with surgery or anti-cancer drug

The patients with asthma will be treated with steroid

Key exclusion criteria

the case that the patient does not agree with this study enroll

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuyuki Kobayashi

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratory Medicine, Department of Internal Medicine

Zip code


Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratory Medicine, Department of Internal Medicine

Zip code


Address


TEL


Homepage URL


Email

kkoba@med.kobe-u.ac.jp


Sponsor or person

Institute

Division of Respiratory Medicine, Department of Internal Medicine,
Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 05 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2009 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 07 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 05 Month 11 Day

Last modified on

2009 Year 05 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002384


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name